Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Investors Guide to Crescent Energys Quarterly Earnings What to Watch for on March 4 2024

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_ blue chart
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Crescent Energy (NYSE: CRGY) is set to unveil its latest quarterly earnings report on March 4, 2024. Here are some key points for investors to keep in mind prior to the big reveal:

– Analysts are anticipating an earnings per share (EPS) of $0.15 for this quarter.
– It’s not just about beating the EPS estimate; investors should also pay attention to the guidance provided for future growth, as this can have a significant impact on stock prices.
– In the previous quarter, Crescent Energy exceeded the EPS estimate by $0.52, resulting in an 8.51% drop in share price the next day.
– Stock performance as of February 28 shows shares trading at $11.18, reflecting a 7.37% decline over the past year.
– With an Earnings ESP of -1.56%, predicting whether Crescent Energy will surpass the consensus EPS estimate is challenging.

In summary, while surpassing earnings estimates is important, investors should closely monitor Crescent Energy’s guidance and future growth forecasts, as these factors can greatly influence stock performance following the earnings release.

CRGY Stock Shows Positive Momentum with 1.07% Increase – March 1, 2024

On March 1, 2024, CRGY stock showed some positive momentum as it experienced a 1.07% increase in its share price. The stock opened at $11.30, which was $0.12 higher than its previous close. This increase in price is a good sign for investors, indicating that there is some bullish sentiment surrounding the stock. However, despite this increase, CRGY is still trading in the middle of its 52-week range and below its 200-day simple moving average. This suggests that the stock may not be experiencing strong upward momentum in the long term. Investors should be cautious when considering CRGY as an investment option. It is important to conduct thorough research and analysis before making any investment decisions.

CRGY Stock Analysis: Revenue Surges While Net Income Fluctuates

On March 1, 2024, CRGY stock had some interesting performances based on the financial data provided by CNN Money. The company’s total revenue stood at $3.06 billion for the past year, showing a significant increase of 106.98% compared to the previous year. Additionally, the total revenue for the last quarter was $642.40 million, marking a 30.48% increase since the previous quarter.

In terms of net income, CRGY reported a net income of $96.67 million for the past year. This represents a substantial increase of 598.94% compared to the previous year. However, the net income for the last quarter was -$52.87 million, indicating a significant decrease of 1126.4% since the previous quarter.

Furthermore, the earnings per share (EPS) for CRGY stock was $2.19 for the past year, showing a remarkable increase of 574.58% compared to the previous year. However, the EPS for the last quarter was -$0.67, reflecting a significant decrease of 739.11% since the previous quarter.

These financial indicators suggest that CRGY has experienced strong revenue growth over the past year, but there have been fluctuations in net income and EPS, particularly in the last quarter. Investors should closely monitor these financial metrics to assess the company’s performance and make informed investment decisions.

Tags: CRGY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Bull Market

Amazon A Stock Market Success Story

Anticipating Cara Therapeuticss Earnings Report What Investors Need to Know

Technology Data analytics Stock Exchange

Dont Miss Out on GitLabs Upcoming Earnings Report

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com